Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
ADCT	ADC THERAPEUTICS SA	Switzerland	$339.54M	82,814,000	41.76%	37.34%	Net Selling	Net Selling
KPTI	KARYOPHARM THERAPEUTICS INC	United States	$135.37M	117,710,263	63.52%	31.99%	Net Selling	Net Selling
LBPH	LONGBOARD PHARMACEUTICALS INC	United States	$804.43M	38,880,054	99.92%	0.08%	Net Selling
NXGL	NEXGEL INC	United States	$14.73M	6,227,624	2.42%	31.25%	Net Buying	Net Buying
FBRX	FORTE BIOSCIENCES INC	United States	$21.90M	36,442,380	52.27%	22.27%	Net Buying	Net Selling
ITOS	ITEOS THERAPEUTICS INC	United States	$652.02M	36,122,922	59.77%	40.23%	Net Buying	Net Buying
ETNB	89BIO INC	United States	$849.05M	98,383,998	86.47%	13.53%	Net Buying	Net Buying
PIRS	PIERIS PHARMACEUTICALS INC	United States	$14.48M	1,320,240	89.00%	11.00%	Net Buying
NUVL	NUVALENT INC	United States	$4.58B	64,556,130	70.70%	29.30%	Net Selling	Net Selling
IGC	IGC PHARMA INC	United States	$35.69M	63,734,439	3.70%	27.99%	Net Buying	Net Buying
IONM	ASSURE HOLDINGS CORP	United States	$3.84M	9,000,000	2.25%	95.40%
AVNS	AVANOS MEDICAL INC	United States	$935.98M	45,903,911	94.00%	2.96%	Net Buying	Net Buying
AEZS	AETERNA ZENTARIS INC	Canada	$10.34M	1,213,969	4.02%	0.00%
MYGN	MYRIAD GENETICS INC	United States	$2.29B	90,507,981	92.82%	7.18%	Net Selling	Net Selling
ABVX	ABIVAX SA	France	$858.35M	62,928,818	37.14%	0.00%
KRMD	KORU MEDICAL SYSTEMS INC	United States	$104.34M	45,764,225	40.92%	49.24%	Net Buying	Net Buying
JSPR	JASPER THERAPEUTICS INC	United States	$347.27M	15,085,553	20.65%	79.35%	Net Buying	Net Buying
XGN	EXAGEN INC	United States	$32.66M	17,373,482	35.48%	64.52%	Net Buying	Net Buying
CYTO	ALTAMIRA THERAPEUTICS LTD	Bermuda	$2.31M	1,477,785	0.11%	0.00%
PULM	PULMATRIX INC	United States	$6.98M	3,652,285	3.54%	96.46%
VKTX	VIKING THERAPEUTICS INC	United States	$7.39B	110,268,210	72.41%	9.00%	Net Selling	Net Selling
GTBP	GT BIOPHARMA INC	United States	$4.42M	1,416,651	49.22%	50.78%	Net Buying
ENTA	ENANTA PHARMACEUTICALS INC	United States	$256.91M	21,179,400	61.16%	38.84%	Net Selling	Net Buying
OCX	ONCOCYTE CORP	United States	$39.16M	13,364,637	5.72%	94.28%	Net Buying	Net Buying
XTNT	XTANT MEDICAL HOLDINGS INC	United States	$93.76M	130,216,541	40.34%	59.66%	Net Selling
HCAT	HEALTH CATALYST INC	United States	$410.29M	59,034,936	75.01%	24.99%	Net Selling	Net Selling
VERA	VERA THERAPEUTICS INC	United States	$2.26B	54,701,217	60.46%	39.54%	Net Selling	Net Selling
RLAY	RELAY THERAPEUTICS INC	United States	$881.40M	132,741,677	72.60%	27.40%	Net Selling	Net Selling
ALRN	AILERON THERAPEUTICS INC	United States	$81.39M	21,589,576	4.75%	95.25%	Net Selling	Net Selling
PCVX	VAXCYTE INC	United States	$8.11B	108,795,188	85.54%	14.46%	Net Selling	Net Buying
GHRS	GH RESEARCH PLC	Ireland	$655.55M	52,028,145	56.89%	0.00%
RCM	R1 RCM INC	United States	$5.24B	421,255,230	45.28%	54.72%	Net Selling	Net Selling
MLSS	MILESTONE SCIENTIFIC INC	United States	$52.67M	77,227,714	5.35%	57.13%	Net Buying	Net Buying
RBOT	VICARIOUS SURGICAL INC	United States	$62.12M	147,215,560	42.65%	53.86%	Net Buying	Net Selling
DMTK	DERMTECH INC	United States	$17.45M	34,962,994	12.14%	76.98%	Net Selling	Net Selling
NKTR	NEKTAR THERAPEUTICS	United States	$322.26M	183,624,620	61.48%	14.12%	Net Selling	Net Selling
ESTA	ESTABLISHMENT LABS HOLDINGS INC	British Virgin Islands	$1.56B	27,514,756	78.55%	21.45%	Net Buying	Net Buying
ABUS	ARBUTUS BIOPHARMA CORP	Canada	$562.38M	188,717,409	25.78%	74.22%	Net Selling
QNCX	QUINCE THERAPEUTICS INC	United States	$39.11M	43,215,233	15.12%	84.88%	Net Buying
TBIO	TELESIS BIO INC	United States	$7.57M	1,682,794	24.17%	75.83%	Net Selling	Net Selling
GKOS	GLAUKOS CORP	United States	$5.53B	50,367,507	63.85%	36.15%	Net Selling	Net Selling
PRPH	PROPHASE LABS INC	United States	$95.97M	19,078,529	8.91%	54.08%
MYO	MYOMO INC	United States	$104.89M	28,814,637	34.49%	11.39%	Net Buying	Net Selling
NVCR	NOVOCURE LTD	Jersey	$2.37B	107,611,077	58.18%	41.82%	Net Buying	Net Buying
AYTU	AYTU BIOPHARMA INC	United States	$16.37M	5,568,158	5.73%	94.27%	Net Buying
ADAP	ADAPTIMMUNE THERAPEUTICS PLC	United Kingdom	$284.24M	1,533,371,874	8.14%	91.86%	Net Selling
GHSI	GUARDION HEALTH SCIENCES INC	United States	$10.93M	1,284,156	0.41%	99.59%
TDOC	TELADOC HEALTH INC	United States	$2.16B	169,588,171	76.24%	6.91%	Net Selling	Net Selling
JYNT	JOINT CORP	United States	$257.85M	14,973,910	55.84%	44.16%	Net Buying
IBRX	IMMUNITYBIO INC	United States	$5.29B	691,567,961	9.56%	7.74%	Net Buying
DRRX	DURECT CORP	United States	$28.87M	31,039,381	8.83%	91.17%
DOMH	DOMINARI HOLDINGS INC	United States	$12.83M	5,995,065	7.16%	92.84%	Net Buying	Net Buying
LIVN	LIVANOVA PLC	United Kingdom	$3.36B	54,151,745	90.95%	9.05%	Net Selling	Net Selling
BKD	BROOKDALE SENIOR LIVING INC	United States	$1.33B	193,012,561	39.91%	60.09%	Net Selling	Net Selling
AVDL	AVADEL PHARMACEUTICALS PLC	Ireland	$1.49B	96,118,523	71.17%	13.53%	Net Selling
SCLX	SCILEX HOLDING CO	United States	$163.07M	181,189,935	15.54%	34.69%	Net Buying	Net Buying
SLN	SILENCE THERAPEUTICS PLC	United Kingdom	$1.01B	131,881,115	20.95%	0.00%
TVTX	TRAVERE THERAPEUTICS INC	United States	$461.34M	76,129,018	60.31%	39.69%	Net Selling	Net Selling
VBIV	VBI VACCINES INC	United States	$18.07M	28,682,275	3.63%	96.37%	Net Buying
MGRM	MONOGRAM ORTHOPAEDICS INC	United States	$65.56M	31,670,375	1.22%	23.61%
PYPD	POLYPID LTD	Israel	$7.14M	1,653,559	66.54%	0.00%
NTRB	NUTRIBAND INC	United States	$49.04M	10,969,870	2.19%	51.68%
BTAI	BIOXCEL THERAPEUTICS INC	United States	$77.69M	37,530,821	4.29%	95.71%	Net Selling	Net Selling
ASND	ASCENDIS PHARMA A	Denmark	$7.05B	58,224,419	100.00%	0.00%
RDHL	REDHILL BIOPHARMA LTD	Israel	$18.13M	12,746,797,800	0.02%	0.00%
DH	DEFINITIVE HEALTHCARE CORP	United States	$867.34M	157,697,413	28.22%	71.78%	Net Selling	Net Selling
CDMO	AVID BIOSERVICES INC	United States	$578.94M	63,479,794	91.91%	8.09%	Net Selling	Net Selling
MOR	MORPHOSYS AG	Germany	$2.86B	37,655,137	29.73%	0.00%
HROW	HARROW INC	United States	$593.00M	35,381,935	28.65%	71.35%	Net Selling	Net Buying
AIH	AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LTD	China	$23.82M	143,363,884	0.31%	1.71%
RNLX	RENALYTIX PLC	United Kingdom	$39.60M	154,368,191	2.61%	11.44%	Net Buying	Net Buying
ATRA	ATARA BIOTHERAPEUTICS INC	United States	$73.45M	120,416,138	69.16%	11.03%	Net Buying	Net Selling
BBIO	BRIDGEBIO PHARMA INC	United States	$5.63B	187,129,260	56.56%	43.44%	Net Selling	Net Selling
TCRX	TSCAN THERAPEUTICS INC	United States	$474.71M	52,862,805	64.87%	26.93%	Net Buying
AZTA	AZENTA INC	United States	$2.74B	53,918,934	81.75%	18.25%	Net Selling	Net Selling
XAIR	BEYOND AIR INC	United States	$49.37M	36,039,056	46.59%	20.17%	Net Buying	Net Buying
NDRA	ENDRA LIFE SCIENCES INC	United States	$3.39M	11,035,659	2.08%	8.73%
DYNT	DYNATRONICS CORP	United States	$2.24M	5,308,519	2.53%	97.47%	Net Buying
PTIX	PROTAGENIC THERAPEUTICS INC	United States	$6.65M	4,435,132	12.12%	1.03%	Net Buying
LCTX	LINEAGE CELL THERAPEUTICS INC	United States	$203.90M	188,798,145	39.25%	60.75%	Net Buying
ENLV	ENLIVEX THERAPEUTICS LTD	Israel	$26.22M	18,598,555	1.75%	77.27%
INSM	INSMED INC	United States	$3.68B	148,604,548	79.77%	20.23%	Net Selling	Net Selling
BVS	BIOVENTUS INC	United States	$507.94M	79,614,354	30.11%	69.89%	Net Buying	Net Selling
GLSI	GREENWICH LIFESCIENCES INC	United States	$180.04M	12,878,409	4.80%	95.20%	Net Buying	Net Buying
TIL	INSTIL BIO INC	United States	$74.80M	6,503,913	5.28%	94.72%
PTPI	PETROS PHARMACEUTICALS INC	United States	$4.10M	7,000,195	0.92%	82.74%
BIO	BIO-RAD LABORATORIES INC	United States	$8.38B	28,524,797	22.22%	77.78%	Net Buying	Net Selling
CMND	CLEARMIND MEDICINE INC	Canada (Federal Level)	$3.87M	3,169,570	4.84%	0.00%
INZY	INOZYME PHARMA INC	United States	$284.54M	61,855,509	54.56%	45.44%	Net Buying	Net Selling
VRCA	VERRICA PHARMACEUTICALS INC	United States	$367.78M	42,420,053	40.75%	59.25%	Net Buying
CERT	CERTARA INC	United States	$2.59B	160,841,451	73.54%	26.46%	Net Selling	Net Selling
GNTA	GENENTA SCIENCE SPA	Italy	$60.12M	18,216,958	2.37%	0.00%
ZIMV	ZIMVIE INC	United States	$464.45M	27,288,700	86.22%	13.78%	Net Selling	Net Selling
RLYB	RALLYBIO CORP	United States	$73.37M	41,449,297	42.04%	57.96%
UBX	UNITY BIOTECHNOLOGY INC	United States	$24.85M	16,789,577	21.33%	51.50%	Net Selling	Net Selling
PDSB	PDS BIOTECHNOLOGY CORP	United States	$128.01M	36,679,275	20.72%	31.97%
BMEA	BIOMEA FUSION INC	United States	$439.96M	35,944,584	64.40%	35.60%	Net Selling
VOR	VOR BIOPHARMA INC	United States	$123.55M	68,259,602	86.36%	10.15%	Net Selling	Net Selling
SRRK	SCHOLAR ROCK HOLDING CORP	United States	$996.13M	79,754,065	61.63%	38.37%	Net Buying
CELC	CELCUITY INC	United States	$523.42M	31,230,085	70.86%	14.94%	Net Selling	Net Selling

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	679	-0.70%	+1.84%	+3.96%	-19.69%	8.47x	6.01x	+18.62%	+3.83%	-27.52%	+77.73%	Strong Buy
Diagnostics & Research	64	-0.44%	+1.56%	+12.99%	+11.25%	38.96x	4.47x	-13.18%	+6.48%	+11.49%	+5.02%	Buy
Drug Manufacturers - General	18	-0.03%	+1.66%	+7.51%	+18.11%	31.85x	6.42x	+33.60%	+8.10%	+14.22%	+11.01%	Buy
Drug Manufacturers - Specialty & Generic	87	-0.75%	+1.10%	+5.60%	-1.99%	-1.01x	2.20x	+12.36%	+3.36%	+6.05%	+32.29%	Strong Buy
Healthcare Plans	12	+0.52%	+1.22%	+4.66%	+4.46%	25.53x	3.07x	+15.18%	+4.74%	+11.78%	+11.78%	Buy
Health Information Services	61	+0.25%	+2.04%	-0.03%	-19.66%	9.15x	3.33x	+6.71%	+2.23%	+5.33%	+26.88%	Buy
Medical Care Facilities	51	-0.09%	+0.01%	+4.96%	+11.10%	39.23x	4.59x	-92.23%	+6.58%	+13.66%	+15.22%	Buy
Medical Devices	150	-0.35%	+1.37%	+2.08%	-13.46%	30.60x	4.00x	+7.35%	+5.26%	+8.26%	+19.86%	Buy
Medical Distribution	10	+0.87%	+0.34%	+1.16%	+26.37%	26.84x	107.17x	-11.87%	+3.44%	+19.58%	+10.98%	Buy
Medical Instruments & Supplies	56	+0.16%	+1.85%	+6.62%	-5.76%	59.83x	3.64x	+11.25%	+7.73%	+10.05%	+18.23%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -42.43% over the past year, underperforming other healthcare stocks by -37 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 33.84% from Cross Country Healthcare's current stock price of $14.57.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 14.93% over the past year, overperforming other healthcare stocks by 21 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 44.77% from Corcept Therapeutics's current stock price of $28.09.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) is the third best healthcare stock with a Zen Score of 65, which is 41 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 12.82% over the past year, overperforming other healthcare stocks by 19 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 104.84% from Kamada's current stock price of $5.37.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Sanofi (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.1%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.93%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.88%, which is 6 percentage points higher than the healthcare sector average of 2.05%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.28% in the last day, and up 1.47% over the last week. Heart Test Laboratories was the among the top losers in the healthcare sector, dropping -38.37% yesterday.

Heart Test Laboratories shares are trading lower after the company's 1-for-100 reverse stock split began trading on a split-adjusted basis.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.03% in the past year. It has underperformed other stocks in the healthcare sector by -38 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -23.81% in the past year. It has underperformed other stocks in the healthcare sector by -18 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -42.43% in the past year. It has underperformed other stocks in the healthcare sector by -37 percentage points.

Are healthcare stocks a good buy now?

50.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.6% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.